| abstract |
A sterile artificial bone product is provided. The sterile artificial bone product comprises a sintered porous ceramic foam material having a density of 0.3 to 1.5 g/cc, and a porosity of 40 to 95%, pores of the material having a pore diameter distribution of 10-500 microns. Additionally, a bioactive compound is coupled to the ceramic foam material. Other embodiments are also described. |